Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ARC International Announces Unaudited Preliminary Results for the Year Ended 31
Reply New Message
Prev Message Back To Forum Threaded View Next Message

ARC International Announces Unaudited Preliminary Results for the Year Ended 31

posted on Feb 14, 2007 09:08AM

ARC Exceeds Market Expectations and Generates Positive Cash Flow with 28% Revenue Growth  

http://www.us.design-reuse.com/news/news15256.html

ARC names Turley to marketing post

http://www.us.design-reuse.com/news/news2084.html

 

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply